Willing to Be Involved in Cancer
AbstractGenome sequencing is now a common procedure, but prior to this, screening experiments using protein baits was one of the routinely used methods that, occasionally, allowed the identification of new gene products. One such experiment uncovered the gene product called willin/human Expanded/FRMD6. Initial characterization studies found that willin bound phospholipids and was strongly co-localised with actin. However, subsequently, willin was found to be the closest human sequence homologue of the Drosophila protein Expanded (Ex), sharing 60% homology with the Ex FERM domain. This in turn suggested, and then was proven that willin could activate the Hippo signalling pathway. This review describes the increasing body of knowledge about the actions of willin in a number of cellular functions related to cancer. However, like many gene products involved in aspects of cell signalling, a convincing direct role for willin in cancer remains tantalisingly elusive, at present. View Full-Text
Share & Cite This Article
Gunn-Moore, F.J.; Tilston-Lünel, A.M.; Reynolds, P.A. Willing to Be Involved in Cancer. Genes 2016, 7, 37.
Gunn-Moore FJ, Tilston-Lünel AM, Reynolds PA. Willing to Be Involved in Cancer. Genes. 2016; 7(7):37.Chicago/Turabian Style
Gunn-Moore, Frank J.; Tilston-Lünel, Andrew M.; Reynolds, Paul A. 2016. "Willing to Be Involved in Cancer." Genes 7, no. 7: 37.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.